Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Diamonds and Dogs

September 19, 2012

Questcor Pharmaceuticals Inc. (QCOR)

Questcor was on a quest to be the largest loser today, closing down 47% at $26.35. The prescription drug company saw its shares crash after news was release that Aetna dropped most of its coverage of Questcor's drug Achtar. Aetna disclosed that after studies, it found no proof of efficacy to substantiate reimbursement for Questcor's Achtar when treating multiple sclerosis and nephrotic syndrome. The news sent Questcor spiraling down 55% before being halted around 11:00AM. The stock resumed trading numerous times before a second and third halt. A wild ride for investors in Questcor's stock today.

Chiquita Brands International Inc. (CQB)

Chiquita Brands has investors going bananas today, up 13.5% at $7.32. The banana and fresh produce distributor saw its shares climb higher today thanks to an upgraded. BB&T Capital Markets upgraded their rating on Chiquita from hold to buy with a price target of $9 a share. The company has struggled to remain profitable and stop burning through cash, however several analysts think Chiquita will grow its profits 10% going forward. The BB&T analyst seems to believe that Chiquita is done monkeying around with its operations and will be able to capitalize in coming quarters. The company's 52-week high was $10.57, so BB&T's $9.00 price target is quite feasible.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.